| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3801895 | Medicina Clínica | 2011 | 4 Pages |
Abstract
Infliximab provides transient response in steroid-resistant GVHD. However, it is associated with a high rate of infections. Earlier administration of infliximab should be explored to reduce the frequency of infections.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Cristina Motlló, Christelle Ferrà , Laia López, Mireia Morgades, Montserrat Batlle, Josep Maria Ribera,